Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium

Abstract

The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March–September 2020. Nearly all facilities (97%) reported closing or operating at reduced capacity at some point during this period. All facilities were open by August 2020, though 14% were still operating at reduced capacity in September 2020. During periods of re-opening or reduced capacity, 93% of facilities reported prioritizing diagnostic breast imaging over breast cancer screening. For diagnostic imaging, facilities prioritized based on rescheduling canceled appointments (89%), specific indication for diagnostic imaging (89%), patient demand (84%), individual characteristics and risk factors (77%), and time since last imaging examination (72%). For screening mammography, facilities prioritized based on rescheduled cancelations (96%), patient demand (83%), individual characteristics and risk factors (73%), and time since last mammogram (71%). For biopsy services, more than 90% of facilities reported prioritization based on rescheduling of canceled exams, patient demand, patient characteristics and risk factors and level of suspicion on imaging. The observed patterns from this large and geographically diverse sample of facilities in the United States indicate that multiple factors were commonly used to prioritize breast imaging services during periods of reduced capacity.

Women’s Experience With Screening Mammography During the COVID-19 Pandemic: A Multi-Institutional Prospective Survey Study

“…While these local and state mandates were highly variable, all six of our institutions were at least temporarily closed for routine screening. This is in keeping with a recent survey by the Breast Cancer Surveillance Consortium, which revealed that 97% of surveyed United States breast imaging facilities were temporarily closed or operated at reduced capacity between March 2020 and September 2020 ( 8 ).…”

Breast reconstruction during the COVID-19 pandemic: Single institution experience from the pandemic's epicenter in the United States

“…Furthermore, diagnostic studies were prioritized over screening mammography. 5 Interestingly, the 11% decline in mammography observed at our institution is less than the near 90% decline observed nationally. 6 …”

“…As others have noted, breast cancer treatment saw a relatively lower decline in volume compared to mammograms at our institution suggestive that treatment for breast cancer was differentially prioritized over breast cancer screening in the context of severely limited healthcare resources. 5 …”

The 2020 U.S. cancer screening deficit and the timing of adults' most recent screen: A population-based quasi-experiment

“…The dire predictions and early evidence that cancer screening dramatically declined prompted investment and capacity for “return to screening” initiatives and patient prioritization policies (Joung et al 2022; Sprague et al 2021). However, most early predictions focused on the initial decline, as opposed to the subsequent rebound, and so did most of the early research.…”